Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04520997 · ClinicalTrials.gov registry record · NA
Restylane Defyne in a Stepwise Treatment Approach
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT04520997 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 62 participants.
The verdict
NCT04520997, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This was a 12-week study to evaluate the effectiveness and safety of Restylane Defyne when using two different injection approaches, stepwise down-up vs. top-down, when treating the lower face.
Interventions
- DEVICE Restylane Defyne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-12-07 |
| Est. Completion | 2021-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04520997
The ClinicalTrials.gov registry entry for NCT04520997 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane Defyne is the first listed.
NCT04520997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04520997 about?
NCT04520997 is a clinical study titled "Restylane Defyne in a Stepwise Treatment Approach". This was a 12-week study to evaluate the effectiveness and safety of Restylane Defyne when using two different injection approaches, stepwise down-up vs. top-down, when treating the lower face.
What is the current status of trial NCT04520997?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2020-12-07. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT04520997?
The interventions under investigation include: Restylane Defyne (DEVICE).
Who is sponsoring clinical trial NCT04520997?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.